Determination of the Interaction between HER2 Receptor and Tomentosine by Molecular Docking

Year 2025, Volume: 6 Issue: 3, 47 - 52, 01.08.2025

İzzettin Güler , Mehmet Özaslan

https://doi.org/10.55549/zbs.1691749

Abstract

Tomentosine and the HER2 gene are important molecules in cancer research. HER2 is a protein receptor on the cell surface that mediates cell growth signals. This protein encoded by the HER2 gene can cause excessive growth and spread of tumor cells, especially in some types of cancer such as breast cancer. Tomentosine, as a plant-derived compound, attracts attention with studies on its biological effects. The study evaluated the propensity of HER2 protein to bind to tomentosine and the therapeutic potential in cancer cases. The interactions of the molecules were analyzed using AutoDock 4.0. As a result, it was found that there is a multidirectional binding between HER2 and tomentosine, which was measured to be -8.47 (Gibbs free energy). These findings show that there is a high affinity and binding potential between HER2 protein and tomentosine. Therefore, it is thought that this study will provide a pioneer for future invitro studies.

Keywords

: HER2 , Tomentosine , Cancer

References

• Cheng, X. (2024). A Comprehensive Review of HER2 in Cancer Biology and Therapeutics. Genes, 15(7), 903. https://doi.org/10.3390/genes15070903.
• Güçlü, E., Çınar Ayan, İ., Dursun, H. G., & Vural, H. (2022). Tomentosin induces apoptosis in pancreatic cancer cells through increasing reactive oxygen species and decreasing mitochondrial membrane potential. Toxicology in vitro : an international journal published in association with BIBRA, 84, 105458. https://doi.org/10.1016/j.tiv.2022.105458
• He, J., Wu, H., Zhou, Y., & Zheng, C. (2020). Tomentosin inhibit cerebral ischemia/reperfusion induced inflammatory response via TLR4/ NLRP3 signalling pathway - in vivo and in vitro studies. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 131, 110697. https://doi.org/10.1016/j.biopha.2020.110697
• Husunet, M. T., Mısırlı, R. Ç., Istıflı, E. S., & Ila, H. B. (2022). Investigation of the genotoxic effects of patent blue V (E131) in human peripheral lymphocytes and in silico molecular docking. Drug and chemical toxicology, 45(4), 1780–1786. https://doi.org/10.1080/01480545.2021.1878208
• Jahanbin, B., Soleimani, V., Azmoude-Ardalan, F., Afshar, S., & Safaei, M. (2023). Evaluation of HER2 Gene Amplification using CISH in Patients with HER2 2+ (equivocal) Breast Carcinoma based on Immunohistochemistry in Imam Khomeini Cancer Institute from 2016 to 2018: HER2 amplification in breast carcinoma. Archives of Breast Cancer, 10(2), 131–137. https://doi.org/10.32768/abc.2023102131-137
• Lee, C. M., Lee, J., Nam, M. J., Choi, Y. S., & Park, S. H. (2019). Tomentosin Displays Anti-Carcinogenic Effect in Human Osteosarcoma MG-63 Cells via the Induction of Intracellular Reactive Oxygen Species. International journal of molecular sciences, 20(6), 1508. https://doi.org/10.3390/ijms20061508
• Merghoub, N., El Btaouri, H., Benbacer, L., Gmouh, S., Trentesaux, C., Brassart, B., Attaleb, M., Madoulet, C., Wenner, T., Amzazi, S., Morjani, H., & El Mzibri, M. (2017). Tomentosin Induces Telomere Shortening and Caspase-Dependant Apoptosis in Cervical Cancer Cells. Journal of cellular biochemistry, 118(7), 1689–1698. https://doi.org/10.1002/jcb.25826
• Paggi, J. M., Pandit, A., & Dror, R. O. (2024). The Art and Science of Molecular Docking. Annual review of biochemistry, 93(1), 389–410. https://doi.org/10.1146/annurev-biochem-030222-120000
• Park, H. H., Kim, S. G., Kim, M. J., Lee, J., Choi, B. K., Jin, M. H., & Lee, E. (2014). Suppressive effect of tomentosin on the production of inflammatory mediators in RAW264.7 cells. Biological & pharmaceutical bulletin, 37(7), 1177–1183. https://doi.org/10.1248/bpb.b14-00050
• Pathmanathan, N., & Bilous, A. M. (2012). HER2 testing in breast cancer: an overview of current techniques and recent developments. Pathology, 44(7), 587–595. https://doi.org/10.1097/PAT.0b013e328359cf9a.
• Rozenblat, S., Grossman, S., Bergman, M., Gottlieb, H., Cohen, Y., & Dovrat, S. (2008). Induction of G2/M arrest and apoptosis by sesquiterpene lactones in human melanoma cell lines. Biochemical pharmacology, 75(2), 369–382. https://doi.org/10.1016/j.bcp.2007.08.024.
• Rubin, I., & Yarden, Y. (2001). The basic biology of HER2. Annals of oncology : official journal of the European Society for Medical Oncology, 12 Suppl 1, S3–S8. https://doi.org/10.1093/annonc/12.suppl_1.s3.
• Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., Baselga, J., & Norton, L. (2001). Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. The New England journal of medicine, 344(11), 783–792. https://doi.org/10.1056/NEJM200103153441101.
• Wolff, A. C., Hammond, M. E. H., Allison, K. H., Harvey, B. E., Mangu, P. B., Bartlett, J. M. S., Bilous, M., Ellis, I. O., Fitzgibbons, P., Hanna, W., Jenkins, R. B., Press, M. F., Spears, P. A., Vance, G. H., Viale, G., McShane, L. M., & Dowsett, M. (2018). Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 36(20), 2105–2122. https://doi.org/10.1200/JCO.2018.77.8738.
• Yang, H., Zhao, H., Dong, X., Yang, Z., & Chang, W. (2020). Tomentosin induces apoptotic pathway by blocking inflammatory mediators via modulation of cell proteins in AGS gastric cancer cell line. Journal of biochemical and molecular toxicology, 34(8), e22501. https://doi.org/10.1002/jbt.22501.
• Yang, L., Xie, J., Almoallim, H. S., Alharbi, S. A., & Chen, Y. (2021). Tomentosin inhibits cell proliferation and induces apoptosis in MOLT-4 leukemia cancer cells through the inhibition of mTOR/PI3K/Akt signaling pathway. Journal of biochemical and molecular toxicology, 35(4), e22719. https://doi.org/10.1002/jbt.22719. Yarden, Y. (2001). Biology of HER2 and its importance in breast cancer. Oncology, 61(Suppl. 2), 1-13. https://doi.org/10.1159/000055396
• Yu, S. H., Lee, C. M., Ha, S. H., Lee, J., Jang, K. Y., & Park, S. H. (2021). Induction of cell cycle arrest and apoptosis by tomentosin in hepatocellular carcinoma HepG2 and Huh7 cells. Human & experimental toxicology, 40(2), 231–244. https://doi.org/10.1177/0960327120943935